Modulators of CDC2-like kinases (CLKS) and methods of use thereof

  • US 20070248590A1
  • Filed: 12/01/2006
  • Published: 10/25/2007
  • Est. Priority Date: 12/02/2005
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for treating or preventing insulin resistance, a metabolic syndrome, diabetes, or complications thereof, or for increasing insulin sensitivity in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of at least one CLK-inhibiting compound, or a pharmaceutically acceptable salt or prodrug thereof.

View all claims

    Thank you for your feedback